Gadobutrol

钆布醇

Report date: 2022/08/26 10:28:18

Base Information

Drug NameGadobutrol
Drug Alias NameGadobutrolumGadobutrol - Bayer HealthCare PharmaceuticalsGadobutrol injection for MRI of CNS - BayerGd-DO3A-butriolGadovist 1.0 +[15] 
ClassificationSmall moleculesDiagnostic agent (In vivo) > Contrast agent
Mechanisms of ActionMagnetic resonance imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsContrast agentsBrain metastasesDiagnostic agents +[13] 
Global Approved IndicationsContrast agentsDiagnostic agentsVascular Diseases +[5] 
Approved Indications in ChinaDiagnostic agents
Original Approved Country/TerritorySwitzerland
Original Approved Date1998/01/01
Country/TerritoryCzechiaCanadaUnited States +[26] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Shentou Technology Co LtdBayer Vital GmbhBayer AG +[4] 
Inactive CompaniesBayer Schering Pharma AGBayer Healthcare Company Ltd
Active IndicationsContrast agentsDiagnostic agentsBreast Diseases +[9] 
Inactive IndicationsBrain metastasesRenal Artery ObstructionCarotid Stenosis +[4] 

Other Information

ATC CodeV08CA09
Related LinksWikipediaDrugBankKEGG